Search Details

Word: biotechs (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Several years ago, biotech companies began springing up in Cambridge and along Route 128, a major highway that circles Boston. Many of the firms maintain with close ties to researchers at educational institutions in the Boston area. As ties between universities and biotech companies grew closer, the EPA “singled out” academic institutions and began cracking down on their hazardous waste violations, Barkley says...

Author: By Sarah L. Park, CONTRIBUTING WRITER | Title: Scholars Question Waste Rules | 3/5/2002 | See Source »

...markers to about 70 genes, they produced a DNA profile that correlated closely with the women's actual outcomes. "There's not much that stands in the way of this test being used clinically," says Stephen Friend, one of the paper's authors and a co-founder of the biotech firm Rosetta Inpharmatics. Clinical trials could begin, he believes, within the year...

Author: /time Magazine | Title: Rethinking Breast Cancer | 2/18/2002 | See Source »

...What we've been able to show," says Dr. Guy Gammon, vice president of clinical development for CancerVax, the biotech company that makes the vaccine, "is that not only do a majority of patients make an immune response, but that those making a strong response survive longer...

Author: /time Magazine | Title: Vaccines Stage A Comeback | 1/21/2002 | See Source »

Nobody cloned a human last year (at least so far as we know), but a Massachusetts biotech firm managed to create a stir nonetheless just by making a six-celled embryo from a human cell. The goal was to achieve what the company called therapeutic cloning, by which cells are coaxed into generating whatever replacement tissues or organs a patient might need. The House of Representatives, however, voted to ban all human-cloning research--including therapeutic cloning--out of concern that it might be the first step down a slippery slope to a world of Mini-Me's. The Senate...

Author: /time Magazine | Title: Our A To Z Guide To Advances In Medicine | 1/21/2002 | See Source »

Investor dollars are not the only things flowing out of digital technology and into biotech; plenty of high-end hardware and software are following the money. The pursuit of new drugs through genomics and proteomics requires the gathering and sifting of oceanic volumes of data about molecules and their reactions to one another. Vertex Pharmaceuticals, for example, simulates 47 billion reactions between drugs and proteins a day--nearly as many as the number of e-mails sent out in the world every week. This requires the massive deployment of supercomputers and highly sophisticated programming tools--all key elements...

Author: /time Magazine | Title: Crunching Digits for Drugs | 12/24/2001 | See Source »

Previous | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | Next